These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11085711)

  • 21. Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study.
    Ramanathan R; Bhatia JJ; Sekar K; Ernst FR
    J Perinatol; 2013 Feb; 33(2):119-25. PubMed ID: 21886094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial.
    Ainsworth SB; Beresford MW; Milligan DW; Shaw NJ; Matthews JN; Fenton AC; Ward Platt MP
    Lancet; 2000 Apr; 355(9213):1387-92. PubMed ID: 10791521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early administration of surfactant in spontaneous breathing with nCPAP through a thin endotracheal catheter--an option in the treatment of RDS in ELBW infants?
    Kribs A
    J Perinatol; 2009 Mar; 29(3):256. PubMed ID: 19240733
    [No Abstract]   [Full Text] [Related]  

  • 24. [Surfactant therapy of premature infants. Complications and mortality are reduced].
    Hjalmarson O
    Lakartidningen; 1993 Nov; 90(45):3938-40. PubMed ID: 8231562
    [No Abstract]   [Full Text] [Related]  

  • 25. Surfactant for the treatment of respiratory distress syndrome.
    Jobe A; Ikegami M
    Am Rev Respir Dis; 1987 Nov; 136(5):1256-75. PubMed ID: 3314618
    [No Abstract]   [Full Text] [Related]  

  • 26. Surfactant-replacement therapy.
    Avery ME; Merritt TA
    N Engl J Med; 1991 Mar; 324(13):910-2. PubMed ID: 2000113
    [No Abstract]   [Full Text] [Related]  

  • 27. Neurodevelopmental outcomes of very low birth weight preterm infants treated with poractant alfa versus beractant for respiratory distress syndrome.
    Eras Z; Dizdar EA; Kanmaz G; Guzoglu N; Aksoy HT; Altunkaya GB; Canpolat FE; Dilmen U
    Am J Perinatol; 2014 Jun; 31(6):463-8. PubMed ID: 23884719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory distress syndrome in near-term infants.
    Rizzo C; Nisini R; Marzetti G
    J Matern Fetal Neonatal Med; 2002 May; 11(5):350-1. PubMed ID: 12389680
    [No Abstract]   [Full Text] [Related]  

  • 29. Surfactant status in preterm neonates recovering from respiratory distress syndrome.
    Verlato G; Cogo PE; Balzani M; Gucciardi A; Burattini I; De Benedictis F; Martiri G; Carnielli VP
    Pediatrics; 2008 Jul; 122(1):102-8. PubMed ID: 18595992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. History of surfactant from 1980.
    Halliday HL
    Biol Neonate; 2005; 87(4):317-22. PubMed ID: 15985754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New generation synthetic surfactants.
    Curstedt T; Calkovska A; Johansson J
    Neonatology; 2013; 103(4):327-30. PubMed ID: 23736010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curosurf.
    Med Lett Drugs Ther; 2000 Mar; 42(1074):27-8. PubMed ID: 10776410
    [No Abstract]   [Full Text] [Related]  

  • 33. Surfactant for premature infants with respiratory distress.
    Med Lett Drugs Ther; 1990 Jan; 32(809):2-3. PubMed ID: 2294387
    [No Abstract]   [Full Text] [Related]  

  • 34. Surfactant replacement therapy in neonatal respiratory distress syndrome.
    Hellmann J
    Paediatr Anaesth; 1995; 5(2):81-8. PubMed ID: 7489429
    [No Abstract]   [Full Text] [Related]  

  • 35. Surfactant. Evolving issues.
    Kattwinkel J
    Clin Perinatol; 1998 Mar; 25(1):17-32. PubMed ID: 9523072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic surfactants in infants with respiratory distress syndrome.
    Egan EA
    N Engl J Med; 1992 Jun; 326(25):1704; author reply 1704-5. PubMed ID: 1588993
    [No Abstract]   [Full Text] [Related]  

  • 37. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of surfactant replacement therapy on the nursery.
    Nightengale B
    Neonatal Netw; 1992 Jun; 11(4):xiii-xvi. PubMed ID: 1608368
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surfactant therapy in respiratory distress syndrome; a review].
    de Winter JP; van Sonderen L; Egberts J; van Bel F
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2010-3. PubMed ID: 1407190
    [No Abstract]   [Full Text] [Related]  

  • 40. Myth: all surfactants are alike.
    Moya F; Javier MC
    Semin Fetal Neonatal Med; 2011 Oct; 16(5):269-74. PubMed ID: 21515101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.